SNAP-8 — questions, answered plainly.

SNAP-8 (acetyl octapeptide-3) is an N-acetylated 8-residue analog of the SNAP-25 N-terminus used in topical cosmetic formulations and studied in small dermatology cohorts.

No. SNAP-8 is a topical cosmetic peptide, not a neurotoxin. It is proposed to interact with SNARE-complex assembly — a mechanism shared with botulinum-toxin biology — but it is not a botulinum-toxin substitute and the published topical effect sizes are small.

No. SNAP-8 is used as a cosmetic ingredient. There is no FDA, MHRA, or EMA drug approval; cosmetic-ingredient status is a separate regulatory category from drug approval.

Avcil 2020 (Journal of Cosmetic Dermatology, PMID 31134751) reports reduction in periorbital wrinkle metrics following topical microneedle delivery of acetyl hexapeptide and acetyl octapeptide-3 in adult volunteers. Shin 2024 (Annals of Dermatology, PMID 39082657) reports small statistically reported improvements in periorbital wrinkle parameters with microneedle-delivered acetyl peptide combinations.

It is proposed to compete with the SNAP-25 N-terminus during SNARE-complex assembly. The molecular evidence base is limited; mechanism is inferred from sequence homology rather than direct SNARE biochemistry in the cited cosmetic studies.

Cited cosmetic trials are limited to small cohorts and short follow-up. Mechanism is inferred from SNAP-25 homology rather than direct biochemistry. Topical effect sizes in published studies are small — SNAP-8 is not a substitute for botulinum-toxin treatments.